The Validation Gap between Consumer and Clinical Wearable Devices

October 29th @ 4.00pm /12.00pm EDT
Digital Health Lunch

The Validation Gap between Consumer and Clinical Wearable Devices

October 29th @ 4.00pm /12.00pm EDT
Digital Health Lunch

HealthXL virtual lunches convene small groups of thought leads and clients to share insights on key digital health issues. We welcome new experts and clients to join or host their own meetings. If you are interested in this topic, we would love to hear from you.

Through focus groups, we bring together 6-10 thought leaders and industry stakeholders in a series of virtual meetings to collaborate around a defined topic. Each meeting gives the group the opportunity to examine, analyze and collaborate with one another around a digital health topic as well as produce a shareable result.

John Mattison
Asst. Med Director, and CMIO Southern California Region at Kaiser Permanente
LinkedIn Profile
Hiromasa Mori
Head of Neurology Patient Technology Europe, UCB
LinkedIn Profile
Esther Dyson
Executive Founder at Wellville
LinkedIn Profile
John Mattison
CMIO , Arsenal Capital
LinkedIn Profile
Jim O'Donoghue
President , S3 Connected Health
LinkedIn Profile
Graham Jones
Director of Innovation , Novartis
LinkedIn Profile
Barry Greene
Co-founder and CTO at Kinesis Health Technologies
LinkedIn Profile
Nader Alaghband
Founder at Ampersand Health
LinkedIn Profile
Elizabeth Mosher
Project Manager, Telehealth Innovation Center at MedStar Health
LinkedIn Profile

Join us for this 60 minute discussion with senior peers on the validation gap between consumer and clinical wearable devices. Meet new people, gain new insights and leave wanting more.

Digital Health Lunch
When:
October 29th @ 4.00pm /12.00pm EDT
Register your interest
Registration Closed

We want to bring together a small group of pharmaceutical and med device executives along with innovators in the wearable device space to talk about what is needed to move from the potential that consumer wearable devices offer to healthcare provision to actual benefits in a clinical setting. In order for consumer health technologies to become recognized medical devices there are significant technical and clinical validations required.  These validations are key for both regulators and pharma companies to commit the resources required to incorporate these devices into clinical development and treatment pathways at scale. There is a potential for mismatched expectations as to what validation actually means between consumer wearable companies and these other stakeholders with real impacts for timelines and funding for wearables businesses. We want to discuss the journey from consumer wearable to medical device, the collaborations between wearable and pharma companies that are working to bridge the validation gap and make the promise of these technologies a regulated reality.

No items found.
Digital Health Lunch
When:
October 29th @ 4.00pm /12.00pm EDT
Apply to Attend
Registration Closed

Attendees